US$ 25.10
foxo4-dri peptide senolytic 2024 study The disordered p53 transactivation domain is the target of FOXO4 and the compound Frontiers | Senolytic Peptide FOXO4-DRI
Description
Gurnee, IL

Barak MM, Weiner S, Shahar R

Importance of Pharmacokinetic Profile and Variability as Determinants of Dose and Response to Dabigatran, Rivaroxaban, and Apixaban

Determining the appropriate amount of vitamin B12 to take depends on several factors, including age, health status, and dietary habits
